(Q34651191)

3 August 2017

1 reference

title

Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 1: pathophysiology and mechanisms of induction (English)

1 reference

3 August 2017

1 reference

1 reference

Howard C Margolese

1

1 reference

3 August 2017

Guy Chouinard

2

1 reference

3 August 2017

Theodore T Kolivakis

3

1 reference

3 August 2017

Linda Beauclair

4

1 reference

3 August 2017

Robert Miller

5

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 August 2005

1 reference

Canadian Journal of Psychiatry

3 August 2017

published in

1 reference

3 August 2017

volume

50

1 reference

3 August 2017

issue

9

1 reference

3 August 2017

page(s)

541-547

1 reference

Conventional vs. newer antipsychotics in elderly patients

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000907

From chlorpromazine to clozapine--antipsychotic adverse effects and the clinician's dilemma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000907

Neurological syndromes associated with antipsychotic drug use. A special report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000907

Gender differences in tardive dyskinesia: a critical review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000907

21 January 2018

Persistent Dyskinesia

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000907

Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000907

Incidence and correlates of tardive dyskinesia in first episode of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000907

Structural brain differences between never-treated patients with schizophrenia, with and without dyskinesia, and normal control subjects: a magnetic resonance imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000907

Increased dopamine synthesis rate in medial prefrontal cortex and striatum in schizophrenia indicated by L-(beta-11C) DOPA and PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000907

Presynaptic dopaminergic function in the striatum of schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000907

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000907

Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000907

Alterations of benzodiazepine receptors in type II alcoholic subjects measured with SPECT and [123I]iomazenil

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000907

Increased baseline occupancy of D2 receptors by dopamine in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000907

Elevated dopa decarboxylase activity in living brain of patients with psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000907

Manual for the Extrapyramidal Symptom Rating Scale (ESRS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000907

Interactive effect of cytochrome P450 17alpha-hydroxylase and dopamine D3 receptor gene polymorphisms on abnormal involuntary movements in chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000907

Susceptibility to neuroleptic-induced tardive dyskinesia and the T102C polymorphism in the serotonin type 2A receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000907

Antipsychotic-Induced movement disorders in the elderly: epidemiology and treatment recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000907

Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000907

Increased dopamine d(2) receptor occupancy and elevated prolactin level associated with addition of haloperidol to clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000907

Increased dopamine D2 receptor binding after long-term treatment with antipsychotics in humans: a clinical PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000907

Unilateral nigrostriatal lesions induce a bilateral increase in glutamate decarboxylase messenger RNA in the reticular thalamic nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000907

Loss of striatal cholinergic neurons as a basis for tardive and L-dopa-induced dyskinesias, neuroleptic-induced supersensitivity psychosis and refractory schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000907

Neurotoxicity associated with neuroleptic-induced oral dyskinesias in rats. Implications for tardive dyskinesia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000907

Study of neuropathologic changes in the striatum following 4, 8 and 12 months of treatment with fluphenazine in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000907

Decreased choline acetyltransferase immunoreactivity in discrete striatal subregions following chronic haloperidol in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000907

Proton magnetic resonance spectroscopy of the basal ganglia in patients with schizophrenia: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000907

Neural damage in the lenticular nucleus linked with tardive dyskinesia in schizophrenia: a preliminary study using proton magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000907

Cholinergic medication for neuroleptic-induced tardive dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000907

The effects of clozapine on tardive dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000907

The emerging role of clozapine in the treatment of movement disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000907

Striatal enlargement in rats chronically treated with neuroleptic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000907

The effect of clozapine on caudate nucleus volume in schizophrenic patients previously treated with typical antipsychotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000907

Characterization of dopaminergic compounds at hD2short, hD4.2 and hD4.7 receptors in agonist-stimulated [35S]GTPgammaS binding assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000907

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000907

Childhood-onset schizophrenia: brain MRI rescan after 2 years of clozapine maintenance treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000907

An MRI study of basal ganglia volumes in first-episode schizophrenia patients treated with risperidone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000907

Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000907

10.1177/070674370505000907

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference